Familywise error control in multi-armed response-adaptive two-stage designs.

Area of Science:

• Biostatistics
• Clinical Trial Design
• Statistical Inference

Background:

• Comparing multiple treatments to a single control is common in clinical research.
• Existing two-stage trial designs often rely on simulations for statistical testing.
• Response-adaptive randomization and block randomization are key components in sequential trial designs.

Purpose of the Study:

• To develop a simulation-free statistical approach for two-stage clinical trial designs.
• To ensure strong familywise error rate protection in adaptive trial designs.
• To provide a robust method for analyzing data from trials with data-dependent treatment selection.

Main Methods:

• Utilizing a two-stage design with response-adaptive randomization in the first stage and block randomization in the second.
• Developing a novel statistical test that avoids simulation under the global null hypothesis.
• Applying the conditional invariance principle to account for data-dependent design modifications.

Main Results:

• The proposed approach provides strong familywise error rate protection.
• The method is valid for two-stage designs with treatment selection between stages.
• The statistical inference does not require computationally intensive simulations.

Conclusions:

• The presented simulation-free method offers a statistically rigorous and efficient way to analyze two-stage adaptive clinical trials.
• This approach enhances the reliability of statistical comparisons between multiple treatments and a control.
• The conditional invariance principle is effectively applied to adaptive statistical designs.